Current recommendations 1'2 concerning the anaesthetic management of patients receiving monoamine oxidase inhibitors (MAOI) suggest that there is no need to discontinue MAOIs before surgery; morphine or fentanyl may be used; meperidine should be avoided; and the classic triad of "hypoxia, hypercarbia and hypotension" be avoided.
We attempted to follow these guidelines and present a case where MAOIs were continued up to the time of coronary artery bypass grafting (CABG). We are not certain of the underlying cause of death in the ICU but suggest that MAOIs may have played a role and complicated patient management.
Case report
A 64-yr-old man with unstable angina presented for CABG. He was depressed and receiving tranylcypromine (MAOI) 30 mg bid for ten years, chlordiazepoxide 25 mg bid and flurazepam. He had myelodysplasia (lib 87 g.dl -I, WBC 4.9 106-L-I). He had had a myocardial infarction two months before surgery with continuing angina while taking digoxin, furosemide, aspirin, nitroglycerine paste, metoprolo! and diltiazem. He was a smoker and while in hospital developed a left lower lobe (LLL) pneumonia requiring tracheal intubation and pulmonary ventilation for four days. Investigation revealed a normal cardiac output (0.), pulmonary wedge pressure (Pw) and matched LLL abnormalities on ~,'/(~ scan. He was treated with cefoxitin, salbutamol and ipratropium and one month before surgery the chest cleared on physical examination and chest radiography. He was also receiving omeprazole, iron, domperidone, and sulcralfate. On physical examination he was a large man (surface area 2 m 2) and appeared pale but in no distress. Blood pressure was 169/80 mmHg supine and 90/50 mmHg standing. Jugular venous pressure was low and there was no peripheral oedema. The respiratory rate was 12 per min. There were no adventitious sounds.
Persantine thallium scanning demonstrated severe septal, inferior and apical ischaemia and a myocardial infarction in the inferior wall. At coronary catheterization the left main coronary artery was 80% obstructed and the right coronary artery was dominant. Therefore he was placed on an urgent list for CABG. The aspirin was stopped but all other medication was continued including tranylcypromine.
A CABG surgery was performed without difficulty. The preoperative laboratory and cardiovascular data are shown in Table I . Premeditation consisted of morphine 12.5 mg, perphenazine 2.5 rag, isosorbide 15 mg, metoprolol 100 mg, and diltiazem 60 mg. The anaesthetic was fentanyl 7 mg, midazolam 7 nag, and pancuronium 20 mg. Two coronary vessels were grafted successfully. The operative course of the patient was stable at all times including weaning from cardiopulmonary bypass. No inotropes were required in the operating room at any time.
Postoperatively the patient was initially stable but management became increasingly difficult. First, there was uncommonly severe shivering and resistant hypertension. Then, labile hypotension, a high cardiac output and a fever developed. The shivering continued despite normothermia. Hypotensive episodes developed (Table I, 21:15) . The pulmonary artery diastolic to wedge pressure gradient widened and cardiac output increased, Neuromuscular blockade (vecuronium) was employed which controlled the shivering and NE was infused to increase BP. Blood gas analysis at 21:15 indicated a combined metabolic and respiratory acidosis, and hypoxaemia. Despite efforts to control these problems the patient had an asystolic cardiac arrest at 23:15 requiring four minutes of CPR. With epinephrine 1 mg iv normal sinus rhythm and BP retumed.
GLOSSARY OF TERMS
The patient's temperature increased to 38 ~ C over the next six hours (Table II, 6 :00). Blood pressure could only be maintained with norepinephrine at 1.6 mg .hr -1. Cardiac output remained high, and PPad-Pw elevated (Table II, 6 :00). Minute volume (VE) was increased (24:00) but PaCO 2 increased. Progressive increases in VE were required to control the respiratory acidosis (Tables I  and II , 24:00 to 6:00). The chest radiograph indicated pulmonary oedema with the right lower lobe (RLL) spared. The WBC increased as did the serum creatinine concentration. The patient was heparinized, cultures were taken and gentamycin and cefazolin were administered. As the day progressed core temperature increased to 39 ~ C despite cooling and continuous neuromuscular blockade. Cardiac output decreased and BP was difficult to maintain. Besides episodes of tachycardia the ECG remained unchanged. Dopamine and epinephrine were not successful in maintaining (~ and so an IABP was inserted (Table  II, 22:00). The A-a 02 gradient widened, metabolic acidosis developed and urine output decreased. The patient became asystolic at 7:18 the next morning. Post mortem examination was not allowed. Two blood cultures and a urine culture were negative.
Discussion
The diagnosis of pulmonary embolus was considered in view of the high PPad-Pw gradient, the high dead space (PaCO 236 mmHg, VE 16 L. min -I with muscle relaxation to reduce the CO 2 production of shivering) and the absence of perfusion of the RLL on the chest radiograph. A pulmonary angiogram was not carried out because the patient was unstable, kidney failure was imminent and the dye dangerous; we would not have removed a pulmonary embohis (PE) even if it were diagnosed since the cardiac output was high and we would not have inserted an inferior vena cava umbrella at the first embohis. However, the high cardiac output indicated a diagnosis other than pulmonary embolus. An error in the measurement of t) was considered. The temperature measured by the thermistor on the PA catheter agreed with another independent temperature measurement. Two cardiac output machines gave the same answer. An intracardiac shunt could have resulted in a falsely high Q. But there was no change in PO 2 from the CVP to right ventricle to PA ports (therefore not a left to right shunt) and high levels of PEEP improved PaO 2 (sugg.estive it was not a right to left cardiac shunt). Therefore Q appeared to be correct. Sepsis was considered given the high cardiac output, shivering, fever and a high WBC in a patient with myelofibrosis. However, no source was found and cultures of blood and urine were negative. There was no response to antibiotic therapy.
A transfusion reaction may have occurred. Although the patient initially received only his own blood back from the pump, he was transfused with six units of platelets. Therefore the shivering and fever may have represented a reaction. However, no hives, bronchospasm or coagulopathy were noted.
The presence of MAOI's may have resulted in an abnormal reaction generating the entire clinical problem. It is difficult to ascertain to what extent MAOIs were involved given the variable and idiosyncratic nature of reactions in general and the patchy information available in the literature. An often reported, reaction of MAOIs in conjunction with certain narcotics is a syndrome of coma, hyperpyrexia and hypertension. 1'2 We were unable to assess the patient's mental status because neuromuscular blockade was used to control shivering. Certainly hyperpyrexia and hypertension were present. Shivering is not usually a feature of this syndrome but was a prominent feature in this case. It may have appeared initially because the patient was hypothermic. Because this syndrome has been reported in conjunction with meperidine and not fentanyl we avoided meperidine and used fentanyl. Upon reviewing the literature (see below) we now question whether this conclusion was well founded.
If the patient's problems originated from something other than MAOIs, it is possible that their presence complicated another diagnosis and/or interfered with pharmacotherapy. 
Discussion of literature

Reactions of patients to meperidine while on MAOIs
There are 12 case reports in the literature that implicate this combination. 3-t3 This "unusual reaction" results in hyperthermia, coma and usually hypertension but occasionally hypotension. In two cases, treatment with phenothiazines was thought to be effective. 3"4 In two others, steroids were thought to be effective 5 but in another case, steroids were not effective. 1~ Only one study reported giving meperidine to patients taking MAOIs in an attempt to elicit an adverse response. 13 None of the 15 patients reacted. This suggests the "unusual reaction" is idiosyncratic and raises the issue of the frequency of the adverse event. The frequency has not been tested but the lack of response in 15 patients tested suggests it is rare.
In animals there are very different results depending on the species. In mice, morphine, pentazocine, phenazocine and meperidine all increased the LDs0 by 40-50% when receiving MAOIs. 14 Morphine has been given without effect to humans on MAOI who later reacted to meperidine. 6 Pentazocine and phenazocine have not been associated with reactions in humans, ts In rabbits, meperidine consistently increased temperature in association with MAOIs l~ but in 15 humans tested it did not. is Therefore animal results from the combination of meperidine and MAOIs are very different from human results.
The mechanism of action that leads to the "unusual reaction" has been suggested to be an increase in the cerebral concentration of 5 H-T. 14 This results from MAOIs but is potentiated by meperidine which blocks neuronal uptake of 5 H-T. The "unusual reaction" is thought to occur in only 20% of cases because the cerebral concentration of 5 H-T must reach a critical level. 16 Animals treated with 5 H-T inhibitors do not increase cerebral 5 H-T and do not show the "unusual reaction." Unfortunately animals do not react in the same way as humans to the combination ofmeperidine and MAOIs (see above). Thus other authors suggest it is an idiosyncratic reaction 17 and we conclude we do not understand the mechanism of action of the "unusual reaction."
Reactions of patients to fentanyl while on MAOIs
There are five cases reported where fentanyl was given to a patient on MAOIs) s''9 None of these cases presented any problem. The conclusion cannot be made from these few patients that a problem does not exist. If the incidence of an idiosyncratic reaction is as rare as it appears to be with meperidine (where the advice is that we must not give meperidine to a patient taking MAOIs) we simply have insufficient data to determine if fentanyl reacts with patients receiving MAOIs.
Animal data are not helpful. One study of eight dogs found no reaction when fentanyl was given to dogs on MAOIs.* The species differences demonstrated with the meperidine data between humans, rabbits and mice bring into serious question the usefulness of the dog data.
We conclude there is simply insufficient data to help us answer the question "is fentanyl safe when patients are taking MAOIs?" Case reports describing cases with a combination of fentanyl and MAOIs should be encouraged (whether or not there is an "unusual reaction"). Certainly no one should feel comfortable with the conclusion in two recent review articles that patients on MAOIs can be given fentanyl safely) '~ Those conclusions are based on inadequate information.
Reactions of patients to phenothiazines while on MAOIs
Phenothiazines have been recommended and used to treat patients with the "unusual reaction" to meperidine while receiving MAOIs 3'4 but three fatalities have been reported with the combination of phenothiazines and MAOls. ~~ One patient who died was hyperthermic and we are not told the temperature in the other two cases. The cause of these reactions is unknown and presumably rare since the combination of MAOIs and phenothiazines has been recommended in patients with psychiatric conditions.
MAOIs and inotropes
In view of the many effects of MAOIs on monoamine metabolism (e.g., epinephrine, norepinephrine, dopamine), we expect unusual results when any of these drugs are given to patients on MAOIs_ But Boakes et al. ~2 found no differences in effects when NE, E, or isuprel were infused before or after MAOIs were given in four human volunteers. Phenylephrine raised BP and HR more after MAOIs than before. This is the only controlled human experiment that tests this question and the MAOI (phenelzine 15 mg rid) was only given for seven days before the inotropes were tested. The experiment can be criticised because of the small numbers of humans tested (since we are concerned about idiosyncracies with MAOI) and because the MAOI was not given for sufficient duration. Once again we do not have sufficient data to conclude either that MAOIs should be continued or discontinued preoperatively when a procedure is undertaken that likely will include the use of inotropes.
Conclusions
That MAOIs interfere with the normal functioning of the autonomic system. Specifically they decrease catecholamine stores, change sensitivity of postsynaptic neurons and the way endogenous or exogenous monoamines are disposed of, result in unpredictable responses to CVS drugs and idiosyncratic and extreme responses to certain drugs, and idiosyncratic and extreme autonomic responses to certain stress. This, combined with the insufficient data on the use of large doses of narcotics in conjunction with MAOIs, suggests that it is logical and prudent to discontinue MAOIs before CABG surgery whenever possible.
There is little evidence to support or refute such a claim. There is some evidence to suggest that surgery that does not involve such stress on the CVS may be safe in the presence of MAOIs. However, only two case reports suggest safety for CABG surgery.
We report a case involving CABG in a patient on MAOIs that resulted in dramatic problems managing the cardiovascular system. We hypothesize that the problems would not have occurred or would have been more easily managed in the absence of the MAOI. We report a case, review the literature and conclude that there is insufficient data to suggest that CABG surgery using high-dose fentanyl in the presence of MAOIs is safe. In view of our lack of knowledge we hope other physicians who have anaesthetized patients on MAOIs will report those experiences.
